Concepedia

Author

Mei‐Jung Lai

Taipei Medical University

Also Known As

M.-D Lai, Mei-Jung Lai, Mei‐Jung Lai

31

Publications

509

Citations

14

H-Index

32

Concepts

All Affiliations

Taipei Medical UniversityNational Health Research InstitutesNational Taiwan UniversityTaipei Medical University HospitalNational Cheng Kung University Hospital
ML

About

Mei‐Jung Lai is an author at Taipei Medical University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

201

2

Natural Sciences

4

4

74

3

Biochemistry

3

3

73

4

Biomolecular Engineering

2

2

24

5

Cell Biology

1

1

17

Mei‐Jung Lai

×

23

Publications

499

Citations

14

H-Index

YearCitations

The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo

Min‐Wu Chao, Mei‐Jung Lai, Jing‐Ping Liou,

Journal of Hematology & Oncology

2015

102

Synthesis and biological evaluation of 1-(4′-Indolyl and 6′-Quinolinyl) indoles as a new class of potent anticancer agents

Mei‐Jung Lai, Jang‐Yang Chang, Hsueh‐Yun Lee,

European Journal of Medicinal Chemistry

2011

34

<i>N</i>-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling

Mei‐Jung Lai, Hsueh‐Yun Lee, Hsun-Yueh Chuang,

Journal of Medicinal Chemistry

2015

29

Synthesis and Structure−Activity Relationships of 2-Amino-1-aroylnaphthalene and 2-Hydroxy-1-aroylnaphthalenes as Potent Antitubulin Agents

G. Randheer Reddy, Ching‐Chuan Kuo, Uan‐Kang Tan,

Journal of Medicinal Chemistry

2008

29

Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms

Kunal Nepali, Hsueh‐Yun Lee, Mei‐Jung Lai,

European Journal of Medicinal Chemistry

2016

26

Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma

Mei-Chuan Chen, Hui-Hsuan Huang, Chin-Yu Lai,

Oncotarget

2015

25

1‐Arylsulfonyl‐5‐(<i>N</i>‐hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors

Hsueh‐Yun Lee, Chia‐Ron Yang, Mei‐Jung Lai,

ChemBioChem

2013

23

1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells

Yimin Liu, Hsueh‐Yun Lee, Chun‐Han Chen,

European Journal of Medicinal Chemistry

2014

22

HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen‐glucose deprivation injuries via H3K14 and H4K5 acetylation‐mediated BDNF expression

Yao‐Ching Fang, Lung Chan, Jing‐Ping Liou,

Journal of Cellular and Molecular Medicine

2020

21

Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma<i>in vitro</i>and<i>in vivo</i>

Han‐Li Huang, Chieh-Yu Peng, Mei‐Jung Lai,

Oncotarget

2014

17

Page 1